ArticleFuture oncology (London, England)2026
Development and validation of a digital pathology artificial intelligence (DPAI)-derived risk score predicting Gleason grade group reclassification for patients who are candidates for active surveillance.
Brent Mabey et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.